Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
161
-
Total 13F shares, excl. options
-
37.9M
-
Shares change
-
+4.77M
-
Total reported value, excl. options
-
$1.99B
-
Value change
-
+$251M
-
Put/Call ratio
-
0.78
-
Number of buys
-
102
-
Number of sells
-
-56
-
Price
-
$52.82
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q3 2016
195 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q3 2016.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 161 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.9M shares
of 58.6M outstanding shares and own 64.57% of the company stock.
Largest 10 shareholders include FMR LLC (6.21M shares), WELLINGTON MANAGEMENT GROUP LLP (5.8M shares), BB BIOTECH AG (2.65M shares), VANGUARD GROUP INC (2.36M shares), Capital International Investors (1.5M shares), Clearbridge Investments, LLC (1.46M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.24M shares), STATE STREET CORP (1.09M shares), Flagship Ventures Management, Inc. (965K shares), and BALYASNY ASSET MANAGEMENT LLC (921K shares).
This table shows the top 161 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.